ADA Scientific Sessions 2025 Abstract

Post Hoc Analysis of Efsubaglutide Alfa Monotherapy and Combined Therapy with Metformin in T2D Patients by Baseline Characteristics

By Yulong Xu, Yale Duan, Li Zhang, Qinghua Wang

Trial in peopleInterventions

The paper

Yulong Xu, Yale Duan, Li Zhang, Qinghua Wang

Shanghai

ADA Scientific Sessions 2025 Abstract, 13 Jun 2025

Presented at ADA Scientific Sessions 2025, poster 739-P

doi.org/10.2337/db25-739-p

The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial
Diabetes, Obesity & Metabolism4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Lancet4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes